Dabrafenib plus trametinib in patients with BRAF.

Subbiah, V; Lassen, U; EElez, E; Italiano, A; Curigliano, G; Javle, M; de Braud, F; Pra-ger, GW; Greil, R; Stein, A; Fasolo, A; Schellens, JHM; Wen, PY; Viele, K; Boran, AD; Gasal, E; Burgess, P; Ilankumaran, P; Wainberg, ZA. Lancet Oncol. 2020; 21(9):1234-1243.

A cross-trial comparison of single-agent ibrutinib.

Tedeschi, A; Greil, R; Demirkan, F; Robak, T; Moreno, C; Barr, PM; Anz, B; Simpson, D; Gaidano, G; Bairey, O; Stevens, D; Gill, D; Flinn, IW; Kipps, TJ; Burger, JA; Lin, J; Webb, T; Fedorov, V; Styles, L; Gribben, JG. Haematologica. 2020; 105(4):e164-e168.

TCL1 transgenic mice as a model for CD49d-high chronic lymphocytic leukemia.

Szenes, E; Harzschel, A; Decker, S; Tissino, E; Pischeli, J; Gutjahr, JC; Kissel, S; Pen-nisi, S; Hopner, JP; Egle, A; Zaborsky, N; Dierks, C; Follo, M; Chigaev, A; Zucchetto, A; Greil, R; Gattei, V; Hartmann, TN. LEUKEMIA. 2020; 34(9): 2498-2502.

Stromal cell protein kinase C-β inhibition enhances chemosensitivity in B cell malignancies and overcomes drug resistance.

Park, E; Chen, J; Moore, A; Mangolini, M; Santoro, A; Boyd, JR; Schjerven, H; Ecker, V; Buchner, M; Williamson, JC; Lehner, PJ; Gasparoli, L; Williams, O; Bloehdorn, J; Stilgenbauer, S; Leitges, M; Egle, A; Schmidt-Supprian, M; Frietze, S; Ringshausen, I. Sci Transl Med. 2020 Jan 15;12(526):eaax9340. doi: 10.1126/scitranslmed.aax9340.

Comparison of high tone therapy and transcutaneous electrical nerve stimulation therapy in chemotherapy-induced polyneuropathy.

Schaffler-Schaden, D; Sassmann, R; Johansson, T; Gampenrieder, SP; Rinnerthaler, G; Lampl, K; Herfert, J; Lenzhofer, C; Landkammer, YT; Rieder, F; Greil, R; Flamm, M; Niebauer, J. Medicine (Baltimore). 2020; 99(19): e20149.

Alemtuzumab plus CHOP versus CHOP in elderly patients with peri-pheral T-cell lymphoma: the DSHNHL2006-1B/ACT-2 trial.

Wulf, GG; Altmann, B; Ziepert, M; DxxxAmore, F; Held, G; Greil, R; Tournilhac, O; Relander, T; Viardot, A; Wilhelm, M; Wilhelm, C; Pezzutto, A; Zijlstra, JM; Van Den Neste, E; Lugtenburg, PJ; Doorduijn, JK; van Gelder, M; van Imhoff, GW; Zettl, F; Braulke, F; Nickelsen, M; Glass, B; Rosenwald, A; Gaulard, P; Loeffler, M; Pfreund-schuh, M; Schmitz, N; Trumper, L. Leukemia . 2020 May 7. doi: 10.1038/s41375-020-0838-5. Online ahead of print.

Incidence and risk factors for relapses in HIV-associated non-Hodgkin-lymphoma as observed in the German HIV-related lymphoma cohort study.

Schommers, P, Gillor, D, Hentrich, M, Wyen, C, Wolf, T, Oette, M, Zoufaly, A, Wasmuth, JC, Bogner, JR, Müller, M, Esser, S, Schleicher, A, Jensen, B, Stoehr, A, Behrens, G, Schultze, A, Siehl, J, Thoden, J, Taylor, N, Hoffmann, C. Haematologica. 2018.

Functional and clinical relevance of VLA-4 (CD49d/CD29) in ibrutinib-treated chronic lymphocytic leukemia.

Tissino, E, Benedetti, D, Herman, SEM, Ten Hacken, E, Ahn, IE, Chaffee, KG, Rossi, FM, Dal Bo, M, Bulian, P, Bomben, R, Bayer, E, Härzschel, A, Gutjahr, JC, Postorino, M, Santinelli, E, Ayed, A, Zaja, F, Chiarenza, A, Pozzato, G, Chigaev, A, Sklar, LA, Burger, JA, Ferrajoli, A, Shanafelt, TD, Wiestner, A, Del Poeta, G, Hartmann, TN, Gattei, V, Zucchetto, A. J Exp Med. 2018.

Microenvironment-induced CD44v6 promotes early disease progression in chronic lymphocytic leukemia.

Gutjahr, JC, Szenes, E, Tschech, L, Asslaber, D, Schlederer, M, Roos, S, Yu, X, Girbl, T, Sternberg, C, Egle, A, Aberger, F, Alon, R, Kenner, L, Greil, R, Orian-Rousseau, V, Hartmann, TN. Blood. 2018.

PET-guided treatment in patients with advanced-stage Hodgkins lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group.

Borchmann, P, Goergen, H, Kobe, C, Lohri, A, Greil, R, Eichenauer, DA, Zijlstra, JM, Markova, J, Meissner, J, Feuring-Buske, M, Hüttmann, A, Dierlamm, J, Soekler, M, Beck, HJ, Willenbacher, W, Ludwig, WD, Pabst, T, Topp, MS, Hitz, F, Bentz, M, Keller, UB, Kühnhardt, D, Ostermann, H, Schmitz, N, Hertenstein, B, Aulitzky, W, Maschmeyer, G, Vieler, T, Eich, H, Baues, C, Stein, H, Fuchs, M, Kuhnert, G, Diehl, V, Dietlein, M, Engert, A. Lancet. 2018, 390(10114): 2790-2802.